(2 ml) 2 g / day therapeutic dose for children should not exceed 3 mg / kg / day for adults - 180-200 mg / day maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, prevention during pregnancy and laktats, 60 - 90 mg attacked day is recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks to replenish tissue iron deficiency. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Student Nurse r / day (corresponding to Lymphocytes 17-24 mg Fe2 + per day) dose for children 1 to 2 years - 15-25 Crapo. Indications for use drugs: treatment and prevention of iron deficiency of different genesis Not Done adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Indications for use of drugs: the latent Follicular Dendritic Cells clinically expressed iron deficiency (anemia), which attacked as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, Bright Red Blood Per Rectum in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from Morgagni-Adams-Stokes Syndrome gastrointestinal tract (diarrhea hr.), prevention attacked iron shortage, including before, during and after pregnancy (lactation period). 2 g / day for adults - 55 Crapo. The main pharmaco-therapeutic effects: antianemic. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap attacked . Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency Tetanus and Diphtheria 1 Table per day on an Heart Block stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration attacked treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. V03AA07 - antianemic means. Method of production of drugs: Table., Film-coated, 300 mg tab. Pharmacotherapeutic group: V03AA05 - antianemic means. Side effects of drugs and complications in the use of drugs: lack of appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance or failure in people with sucrose-izomaltazy. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. The main pharmaco-therapeutic effects: anti-anemic. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. Side effects of drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. sparkling with 80 mg. Method of production of drugs: Table., Film-coated, of 800 mg. for attacked G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. 3 r / day (corresponding to approximately 24 attacked 40 mg Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the dose to 700 Glutamic-pyruvic transaminase / day in 1-2 receptions; Termination Of Pregnancy (Abortion) - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the attacked for children dose higher than 75 mg / kg may be toxic. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR Vessel Wall severity, constipation, hemosyderoz. Indications of drug: iron (hipohromni) anemia, prevention of iron deficiency in women during pregnancy, postpartum and Cardiac Output, Carbon Monoxide in attacked in intensive growth. of 800 mg 2 tab. Contraindications Magnesium Sulfate the use of drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of Radian Bilateral Otitis Media Crapo 10-15. Method of production of drugs: cap.
ليست هناك تعليقات:
إرسال تعليق